FDA records linked by MedtechLedger identify Shenzhen Dongdixin Technology Co., Ltd. as an applicant in the premarket notification pathway, with one linked 510(k) record in the current collection. That record is K252288 for TECAR Therapy Device (TC2000, TC2001), decided Substantially Equivalent on 2026-10-13 under product code PBX. Earlier FDA correspondence and summaries name the same Shenzhen firm as correspondent or submitter on electrical stimulation filings, which places its documented activity in Class II device review rather than in an unverified corporate structure. [1][3][6][7]

The TECAR filing and its review scope

K252288 covers TECAR Therapy Device (TC2000, TC2001), received 2025-07-23 and decided 2026-10-13 as Substantially Equivalent. The FDA record lists product code PBX, regulation 878.4400, device name Massager, Vacuum, Radio Frequency Induced Heat, Class II, with the advisory committee described as General, Plastic Surgery. Clearance type is Traditional, the third-party review flag is N, and the statement or summary field reads Statement. [1][6]

The applicant address on the filing is Floor 1-2, #3 Bldg., Fanshen Xusheng Industrial Estate, Xilixiaobaimang, Nanshan District, Shenzhen, postal code 518108, country code CN, with Siping Yuan listed as contact. That is a filing address, not a verified headquarters. The premarket notification listing extract carries the TECAR row immediately before the K252344 Becton Dickinson entry. [1][5]

Earlier stimulation filings naming the same firm

K181102, dated September 15, 2018, concerns ThermaCare Quick Therapy TENS, TC001, under regulation 21 CFR 882.5890, product codes NUH and NYN, Class II. Pfizer Inc. is the submitter and 510(k) owner at 235 East 42nd Street, New York, while Shenzhen Dongdixin Technology Co., Ltd. appears as correspondent at the Xilibaimang Xusheng Industrial Estate address, with Siping Yuan as correspondent contact. [3]

K210364, dated June 17, 2021, is addressed to Shenzhen Dongdixin Technology Co., Ltd. and Siping Yuan for Migraine TENS Digital Pain Reliever, under 21 CFR 882.5891, product code PCC, Class II. K171978, dated October 2, 2017, covers Combo Stimulator MT9000, Combo Stimulator LT7102 and TENS Stimulator InTENSity 10 under 21 CFR 890.5850, product codes IPF, GZJ and LIH, Class II, with the firm named as submitter. [7][8]

What the collection counts do and do not show

The current collection holds one linked record, all in the 510(k) pathway, with a decision count of one Substantially Equivalent. The record sample is the same single entry, so its sample decision count is also one. These figures describe the linked filings at the snapshot date and are not measures of total company sales, total portfolio or safety performance. [1][6]

No recall records appear in the collection. Absence of recalls in this linked set does not establish the firm's recall history or postmarket performance, and no source here documents manufacturing volume, customers or commercial availability of the cleared devices. [1][6]

Applicant identity versus brand relationships

The ThermaCare filing separates roles: Pfizer Inc. is the submitter and owner of that 510(k), and Shenzhen Dongdixin Technology Co., Ltd. is the correspondent. Reading the Dongdixin name as owner of the ThermaCare brand would exceed the record. The TECAR, migraine TENS and combo stimulator filings instead name the Shenzhen firm directly as applicant or submitter. [1][3][7][8]

No source identifies a parent company, subsidiary structure, website or customer list for Shenzhen Dongdixin Technology Co., Ltd. The documented identity rests on FDA applicant and correspondent fields, product codes and regulation numbers across the cited filings. [1][3][6][7][8]